Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer Meeting Abstract
| Authors: | Rieke, D. T.; Lin, J. I.; Tan, D. S.; Kummar, S.; Patel, J. D.; Cermignani, L.; Dai, M. S.; Lassen, U. N.; Leyvraz, S.; Liu, Y.; Moreno, V.; Rosen, L.; Saada-Bouzid, E.; Solomon, B.; Xu, R. H.; Yachnin, J.; Norenberg, R.; Burcoveanu, D. I.; Mussi, C. E.; Shen, L.; Drilon, A. |
| Abstract Title: | Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (2023) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 46 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Oct 13-16 |
| Meeting Location: | Hamburg, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2023-10-01 |
| Start Page: | 9 |
| End Page: | 10 |
| Language: | English |
| ACCESSION: | WOS:001091456900021 |
| PROVIDER: | wos |
| PUBMED: | 37788643 |
| DOI: | 10.1159/000533576 |
| Notes: | Meeting Abstract: V49 -- Source: Wos |
